- Home
- SARS-CoV-2 Omicron Spike Antigens
- SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO)
The Native Antigen
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO)
- SKU:
- REC32009
- UPC:
- MPN:
Description
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO) | REC32009 from Native Antigen is available for delivery.
SARS-CoV-2 Omicron Spike (CHO) protein. Recombinant SARS-CoV-2 Spike protein S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) expressed in CHO cells. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
PRODUCT DETAILS – SARS-COV-2 (B.1.1.529/OMICRON) SPIKE GLYCOPROTEIN (S1), HIS-TAG (CHO)
- SARS-CoV-2 Omicron Spike (CHO), Accession: MN908947
- SARS-CoV-2 (B.1.1.529/Omicron) spike contains A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H mutations relative to Wuhan Hu-1.
- Expressed in CHO cells and purified by affinity chromatography.
- Presented in liquid form in DPBS.
BACKGROUND
South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World Health Organization (WHO) on November 24, 2021. B.1.1.529 was first detected in specimens collected in Botswana and South Africa. On December 1, 2021, the first case attributed to B.1.1.529 was reported in the United States in a person who returned from travel to South Africa. The Omicron variant has since been detected in travel-related cases in an increasing number of European countries, as well as Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, and the United Kingdom. A few countries, including the United States, have reported cases in individuals without travel history to southern Africa.
On November 26, 2021, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) convened to assess B.1.1.529. The TAG-VE advised WHO that this variant should be designated as a Variant of Concern (VOC), and WHO designated B.1.1.529 as a VOC named Omicron. The European Center for Disease Prevention and Control also classified this variant as a VOC due to concerns regarding immune escape and potentially increased transmissibility compared to the Delta variant.
Omicron has a large number of spike protein substitutions, some of which are known from other variants to be associated with reduced susceptibility to available monoclonal antibody therapeutics or reduced neutralization by convalescent and vaccinee sera. The spike protein of the Omicron variant is characterized by at least 30 amino acid substitutions, three small deletions, and one small insertion. Notably, 15 of the 30 amino acid substitutions are in the receptor binding domain (RBD). There are also a number of changes and deletions in other genomic regions. Some diagnostic kits have significantly reduced S-gene target sensitivity due to the deletion at H69 and V70 in the B Omicron spike protein. Specimens being tested using these kits that yield an S gene target failure (SGTF) ‘may’ be Omicron (CDC, 2021).
REFERENCES
- Science Brief: Omicron (B.1.1.529) Variant (CDC).
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern (WHO).
- Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA (ECDC).
Related Products

SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
The Native Antigen

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
The Native Antigen

SARS-CoV-2 Spike Glycoprotein (S1), His-Tag (Insect Cells) | BSV-COV-PR-24
BioServUK

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience
Customers Also Viewed


COVID-19 Spike Protein Accquant® ELISA Kit
Fine Test

SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
The Native Antigen


SARS-CoV-2 Spike Protein Total Antibody ELISA Kit
Elabscience

Anti-FURIN Antibody | Y403880
ABM Good

Anti-Nsp13 Antibody | Y300529
ABM Good

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293)
The Native Antigen

GENLISA™ SARS-CoV-2 (Covid-19) Delta/DeltaPlus Neutralizing Antibody (B.1.617.2, AY.1,AY.2) ELISA
Krishgen

SARS-CoV-2 Y14 | GEN-P0DTD3
Gentaur

SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen

Anti-Nsp3 Antibody | Y300528
ABM Good

abm | SARS-CoV-2 ORF1ab Recombinant Protein, partial (E.coli) | COV01030
ABM Good
xNetic™ Viral DNA/RNA Extraction Kit
LaunchWorks

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen w B.1.351 RBD Mutation (South African Variant)
Genprice Gentaur

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.429 Mutation (U.S. California Variant)
Genprice Gentaur

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.617 Mutation (Indian Variant)
Genprice Gentaur

GSD NovaType Select K417N/T SARS-CoV-2
Eurofins

Recombinant Transmembrane Protease, Serine 2 (TMPRSS2) | RPC795Hu01
Cloud-Clone

Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial | CSB-MP866317HU
Cusabio

SARS-CoV-2 Spike Trimer (T19R, V70F, FR157-158Del, A222V, W258L, K417N, L452R, T478K, D614G, P681R, D950N), His Tag | SPN-C52Ht
Acro Biosystems

SARS-CoV-2 Spike Trimer (E484K, D614G), His Tag (MALS verified) B.1.620 (Africa/Europe) | SPN-C52Hq
Acro Biosystems

SARS-CoV-2 Spike RBD (L452R, E484Q), His Tag (MALS verified) | SPD-C52Hv
Acro Biosystems

SARS-CoV-2 S2 protein (T716I, S982A, D1118H), His Tag | S2N-C52Hd
Acro Biosystems

SARS-CoV-2 M | GEN-P0DTC5
Gentaur

SARS-CoV-2 Spike Glycoprotein | GEN-P0DTC2
Gentaur

SARS-CoV-2 ORF9b | GEN-PO15TF
Gentaur

SARS-CoV-2 ORF8 | GEN-P0DTC8
Gentaur

SARS-CoV-2 ORF7b | GEN-P0DTD8
Gentaur

SARS-CoV-2 ORF7a | GEN-P0DTC7
Gentaur

SARS-CoV-2 ORF6 | GEN-P0DTC6
Gentaur

SARS-CoV-2 ORF3a | GEN-P0DTC3
Gentaur

HCoV-OC43 Spike Glycoprotein | GEN-P36334
Gentaur

SARS-CoV-2 N | S-CP-P2009
Elabscience

Recombinant 2019-nCoV M Protein | 763-PKSV500000
Elabscience

CleanPlex SARS-CoV-2 Panel (8) | 918010
BioServUK

CleanPlex for MGI SARS-CoV-2 Panel (384) | 918003
BioServUK

CleanPlex for MGI SARS-CoV-2 Panel (96) | 918002
BioServUK

CleanPlex for MGI SARS-CoV-2 Panel (8) | 918001
BioServUK

VIRAL DNA/RNA EXTRACTION KIT (300 preparations) | IB47403
BioServUK

VIRAL DNA/RNA EXTRACTION KIT (100 preparations) | IB47402
BioServUK

VIRAL DNA/RNA EXTRACTION KIT (50 preparations) | IB47401
BioServUK

VIRAL DNA/RNA EXTRACTION KIT (sample; 4 preparations) | IB47400
BioServUK

Biotinylated Detection Affimer Reagent | BSV-COV-DET-05
BioServUK

Capture Affimer Reagent 2 | BSV-COV-CA03
BioServUK

Capture Affimer Reagent 1 | BSV-COV-CA01
BioServUK

SARS-CoV-2 Nucleoprotein, His-Tag (E. coli) | BSV-COV-PR-22
BioServUK


Recombinant COVID-19 Omicron S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) protein
Creative BioMart

Recombinant COVID-19 Omicron S-ECD protein, His-tagged, HEK293
Creative BioMart

Recombinant COVID-19 Omicron RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H) protein, His-tagged
Creative BioMart

Recombinant COVID-19 Omicron RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H) protein, His-Avi-tagged, Biotinylated
Creative BioMart

Recombinant COVID-19 Omicron RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) protein, His-Avi-tagged, Biotinylated
Creative BioMart